Finance

Lists
GUD:TSE
Knight Therapeutics Inc
10,69 CA$
+0,09%
(+0,0100) 1D
14 հոկ, 12:10:50 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for GUD...
Open
10,65 CA$
High
10,73 CA$
Low
10,64 CA$
Mkt. cap
1,05 մլրդ
Avg. vol.
83,58 հզր
Volume
7,92 հզր
P/E ratio
71,28
52-wk high
11,00 CA$
52-wk low
5,66 CA$
EPS
0,15 CA$
Beta
-0,07
Shares outstanding
98,23 մլն
No. of employees
830
Open
10,65 CA$
High
10,73 CA$
Low
10,64 CA$
Mkt. cap
1,05 մլրդ
Avg. vol.
83,58 հզր
Volume
7,92 հզր
P/E ratio
71,28
52-wk high
11,00 CA$
52-wk low
5,66 CA$
EPS
0,15 CA$
Beta
-0,07
Shares outstanding
98,23 մլն
No. of employees
830
News stories
From web sources and news partners
Profile
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
About Knight Therapeutics Inc
CEO-
Employees830
Founded2014
HeadquartersՄոնրեալ, Քվեբեկ, Կանադա
Sector-
Last report
06 օգս, 2026 թ.
Fiscal period
Q2 2026
-0,03 CA$ /
0,00%miss
Revenue / Est. (CAD)
144,21 մլն / 128,90 մլն
+11,88%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
121,55 մլն
133,11 մլն
148,44 մլն
144,21 մլն
Cost of goods sold
65,74 մլն
68,38 մլն
79,33 մլն
74,60 մլն
Cost of revenue
65,74 մլն
68,38 մլն
79,33 մլն
74,60 մլն
Research and development expenses
8,69 մլն
9,22 մլն
9,41 մլն
10,56 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31,02 մլն
35,45 մլն
34,45 մլն
36,64 մլն
Operating expense
55,16 մլն
58,51 մլն
58,53 մլն
60,66 մլն
Total operating expenses
120,90 մլն
126,90 մլն
137,86 մլն
135,25 մլն
Operating income
646,00 հզր
6,21 մլն
10,58 մլն
8,96 մլն
Other non operating income
-271,00 հզր
329,00 հզր
4,17 մլն
-487,00 հզր
EBT including unusual items
-1,92 մլն
11,22 մլն
14,18 մլն
-2,10 մլն
EBT excluding unusual items
2,24 մլն
1,57 մլն
15,50 մլն
7,21 մլն
Income tax expense
1,87 մլն
2,37 մլն
1,01 մլն
1,26 մլն
Effective tax rate
-97,76%
21,12%
7,14%
-59,82%
Other operating expenses
-
-
-
-
Net income
-3,79 մլն
8,85 մլն
13,17 մլն
-3,36 մլն
Net profit margin
-3,12%
6,65%
8,87%
-2,33%
Earnings per share
-0,02
0,10
0,14
-0,03
Interest and investment income
1,11 մլն
1,22 մլն
952,00 հզր
901,00 հզր
Interest expense
-2,37 մլն
-3,92 մլն
-2,64 մլն
-2,12 մլն
Net interest expenses
-1,26 մլն
-2,70 մլն
-1,69 մլն
-1,22 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
18,41 մլն
16,47 մլն
26,77 մլն
23,97 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps